21 CFR § 13.15 - Separation of functions; ex parte communications; administrative support.

---
identifier: "/us/cfr/t21/s13.15"
source: "ecfr"
legal_status: "authoritative_unofficial"
title: "21 CFR § 13.15 - Separation of functions; ex parte communications; administrative support."
title_number: 21
title_name: "Food and Drugs"
section_number: "13.15"
section_name: "Separation of functions; ex parte communications; administrative support."
chapter_name: "FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES"
subchapter_number: "A"
subchapter_name: "GENERAL"
part_number: "13"
part_name: "PUBLIC HEARING BEFORE A PUBLIC BOARD OF INQUIRY"
positive_law: false
currency: "2026-04-05"
last_updated: "2026-04-05"
format_version: "1.1.0"
generator: "[email protected]"
authority: "5 U.S.C. 551-558, 701-721; 15 U.S.C. 1451-1461; 21 U.S.C. 141-149, 321-393, 467f, 679, 821, 1034; 28 U.S.C. 2112; 42 U.S.C. 201, 262, 263b-263n, 264."
regulatory_source: "44 FR 22348, Apr. 13, 1979, unless otherwise noted."
cfr_part: "13"
---


# 13.15 Separation of functions; ex parte communications; administrative support.

(a) The proceeding of a Board are subject to the provisions of § 10.55 relating to separation of functions and ex parte communications. Representatives of the participants in any proceeding before a Board, including any members of the office of the Chief Counsel of FDA assigned to advise the center responsible for the matter, may have no contact with the members of the Board, except as participants in the proceeding, and may not participate in the deliberations of the Board.

(b) Administrative support for a Board is to be provided only by the office of the Commissioner and the office of the Chief Counsel for FDA.

[44 FR 22348, Apr. 13, 1979, as amended at 54 FR 9035, Mar. 3, 1989]